The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: Modulation by the p75 neurotrophin receptor

Alla Khodorova, Grant Nicol, Gary Strichartz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The p75 neurotrophin receptor (p75NTR) and its activation of the sphingomyelin signaling cascade are essential for mechanical hypersensitivity resulting from locally injected nerve growth factor (NGF). Here the roles of the same effectors, and of the tropomyosin receptor kinase A (TrkA) receptor, are evaluated for thermal hyperalgesia from NGF. Sensitivity of rat hind paw plantar skin to thermal stimulation after local sub-cutaneous injection of NGF (500 ng) was measured by the latency for paw withdrawal (PWL) from a radiant heat source. PWL was reduced from baseline values at 0.5–22 h by ∼40% from that in naïve or vehicle-injected rats, and recovered to pre-injection levels by 48 h. Local pre-injection with a p75NTR blocking antibody did not affect the acute thermal hyperalgesia (0.5–3.5 h) but hastened its recovery so that it had reversed to baseline by 22 h. In addition, GW4869 (2 mM), an inhibitor of the neutral sphingomyelinase (nSMase) that is an enzyme in the p75NTR pathway, also failed to prevent thermal hyperalgesia. However, C2-ceramide, an analog of the ceramide produced by sphingomyelinase, did cause thermal hyperalgesia. Injection of an anti-TrkA antibody known to promote dimerization and activation of that receptor, independent of NGF, also caused thermal hyperalgesia, and prevented the further reduction of PWL from subsequently injected NGF. A non-specific inhibitor of tropomyosin receptor kinases, K252a, prevented thermal hyperalgesia from NGF, but not that from the anti-TrkA antibody. These findings suggest that the TrkA receptor has a predominant role in thermal hypersensitivity induced by NGF, while p75NTR and its pathway intermediates serve a modulatory role.

Original languageEnglish (US)
Pages (from-to)384-397
Number of pages14
JournalNeuroscience
Volume340
DOIs
StatePublished - Jan 6 2017

Fingerprint

Nerve Growth Factor Receptor
Hyperalgesia
Nerve Growth Factor
Sphingomyelin Phosphodiesterase
Injections
Hot Temperature
Hypersensitivity
Skin
Blocking Antibodies
Sphingomyelins
Antibodies
Ceramides
Dimerization
tropomyosin kinase
Enzymes

Keywords

  • atypical PKC
  • hypersensitivity
  • neurotrophin
  • pain
  • TRPV1

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor : Modulation by the p75 neurotrophin receptor. / Khodorova, Alla; Nicol, Grant; Strichartz, Gary.

In: Neuroscience, Vol. 340, 06.01.2017, p. 384-397.

Research output: Contribution to journalArticle

@article{52df82876e5d4167a101201580c62a52,
title = "The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor: Modulation by the p75 neurotrophin receptor",
abstract = "The p75 neurotrophin receptor (p75NTR) and its activation of the sphingomyelin signaling cascade are essential for mechanical hypersensitivity resulting from locally injected nerve growth factor (NGF). Here the roles of the same effectors, and of the tropomyosin receptor kinase A (TrkA) receptor, are evaluated for thermal hyperalgesia from NGF. Sensitivity of rat hind paw plantar skin to thermal stimulation after local sub-cutaneous injection of NGF (500 ng) was measured by the latency for paw withdrawal (PWL) from a radiant heat source. PWL was reduced from baseline values at 0.5–22 h by ∼40{\%} from that in na{\"i}ve or vehicle-injected rats, and recovered to pre-injection levels by 48 h. Local pre-injection with a p75NTR blocking antibody did not affect the acute thermal hyperalgesia (0.5–3.5 h) but hastened its recovery so that it had reversed to baseline by 22 h. In addition, GW4869 (2 mM), an inhibitor of the neutral sphingomyelinase (nSMase) that is an enzyme in the p75NTR pathway, also failed to prevent thermal hyperalgesia. However, C2-ceramide, an analog of the ceramide produced by sphingomyelinase, did cause thermal hyperalgesia. Injection of an anti-TrkA antibody known to promote dimerization and activation of that receptor, independent of NGF, also caused thermal hyperalgesia, and prevented the further reduction of PWL from subsequently injected NGF. A non-specific inhibitor of tropomyosin receptor kinases, K252a, prevented thermal hyperalgesia from NGF, but not that from the anti-TrkA antibody. These findings suggest that the TrkA receptor has a predominant role in thermal hypersensitivity induced by NGF, while p75NTR and its pathway intermediates serve a modulatory role.",
keywords = "atypical PKC, hypersensitivity, neurotrophin, pain, TRPV1",
author = "Alla Khodorova and Grant Nicol and Gary Strichartz",
year = "2017",
month = "1",
day = "6",
doi = "10.1016/j.neuroscience.2016.10.064",
language = "English (US)",
volume = "340",
pages = "384--397",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - The TrkA receptor mediates experimental thermal hyperalgesia produced by nerve growth factor

T2 - Modulation by the p75 neurotrophin receptor

AU - Khodorova, Alla

AU - Nicol, Grant

AU - Strichartz, Gary

PY - 2017/1/6

Y1 - 2017/1/6

N2 - The p75 neurotrophin receptor (p75NTR) and its activation of the sphingomyelin signaling cascade are essential for mechanical hypersensitivity resulting from locally injected nerve growth factor (NGF). Here the roles of the same effectors, and of the tropomyosin receptor kinase A (TrkA) receptor, are evaluated for thermal hyperalgesia from NGF. Sensitivity of rat hind paw plantar skin to thermal stimulation after local sub-cutaneous injection of NGF (500 ng) was measured by the latency for paw withdrawal (PWL) from a radiant heat source. PWL was reduced from baseline values at 0.5–22 h by ∼40% from that in naïve or vehicle-injected rats, and recovered to pre-injection levels by 48 h. Local pre-injection with a p75NTR blocking antibody did not affect the acute thermal hyperalgesia (0.5–3.5 h) but hastened its recovery so that it had reversed to baseline by 22 h. In addition, GW4869 (2 mM), an inhibitor of the neutral sphingomyelinase (nSMase) that is an enzyme in the p75NTR pathway, also failed to prevent thermal hyperalgesia. However, C2-ceramide, an analog of the ceramide produced by sphingomyelinase, did cause thermal hyperalgesia. Injection of an anti-TrkA antibody known to promote dimerization and activation of that receptor, independent of NGF, also caused thermal hyperalgesia, and prevented the further reduction of PWL from subsequently injected NGF. A non-specific inhibitor of tropomyosin receptor kinases, K252a, prevented thermal hyperalgesia from NGF, but not that from the anti-TrkA antibody. These findings suggest that the TrkA receptor has a predominant role in thermal hypersensitivity induced by NGF, while p75NTR and its pathway intermediates serve a modulatory role.

AB - The p75 neurotrophin receptor (p75NTR) and its activation of the sphingomyelin signaling cascade are essential for mechanical hypersensitivity resulting from locally injected nerve growth factor (NGF). Here the roles of the same effectors, and of the tropomyosin receptor kinase A (TrkA) receptor, are evaluated for thermal hyperalgesia from NGF. Sensitivity of rat hind paw plantar skin to thermal stimulation after local sub-cutaneous injection of NGF (500 ng) was measured by the latency for paw withdrawal (PWL) from a radiant heat source. PWL was reduced from baseline values at 0.5–22 h by ∼40% from that in naïve or vehicle-injected rats, and recovered to pre-injection levels by 48 h. Local pre-injection with a p75NTR blocking antibody did not affect the acute thermal hyperalgesia (0.5–3.5 h) but hastened its recovery so that it had reversed to baseline by 22 h. In addition, GW4869 (2 mM), an inhibitor of the neutral sphingomyelinase (nSMase) that is an enzyme in the p75NTR pathway, also failed to prevent thermal hyperalgesia. However, C2-ceramide, an analog of the ceramide produced by sphingomyelinase, did cause thermal hyperalgesia. Injection of an anti-TrkA antibody known to promote dimerization and activation of that receptor, independent of NGF, also caused thermal hyperalgesia, and prevented the further reduction of PWL from subsequently injected NGF. A non-specific inhibitor of tropomyosin receptor kinases, K252a, prevented thermal hyperalgesia from NGF, but not that from the anti-TrkA antibody. These findings suggest that the TrkA receptor has a predominant role in thermal hypersensitivity induced by NGF, while p75NTR and its pathway intermediates serve a modulatory role.

KW - atypical PKC

KW - hypersensitivity

KW - neurotrophin

KW - pain

KW - TRPV1

UR - http://www.scopus.com/inward/record.url?scp=84998854240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998854240&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2016.10.064

DO - 10.1016/j.neuroscience.2016.10.064

M3 - Article

C2 - 27826102

AN - SCOPUS:84998854240

VL - 340

SP - 384

EP - 397

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -